Press coverage about Walgreens Boots Alliance (NASDAQ:WBA) has been trending positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Walgreens Boots Alliance earned a media sentiment score of 0.26 on Accern’s scale. Accern also gave media stories about the pharmacy operator an impact score of 45.3989047325224 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Here are some of the news articles that may have impacted Accern Sentiment Analysis’s rankings:
- Walgreens to revise Rite Aid stores deal for antitrust approval: Bloomberg (finance.yahoo.com)
- Walgreens to tweak Rite Aid deal to get FTC signoff (seekingalpha.com)
- Walgreens to revise Rite Aid stores deal for antitrust approval – Bbg (feeds.reuters.com)
- Walgreens Said to Tweak Rite Aid Deal to Clinch U.S. Approval (bloomberg.com)
- Walgreens Boots Alliance, Inc. (WBA) Receives Consensus Recommendation of “Buy” from Brokerages (americanbankingnews.com)
Walgreens Boots Alliance (WBA) traded up 0.12% on Monday, reaching $82.60. 6,117,199 shares of the company traded hands. The stock has a market capitalization of $88.39 billion, a price-to-earnings ratio of 20.86 and a beta of 1.26. The stock has a 50 day moving average of $81.35 and a 200-day moving average of $81.89. Walgreens Boots Alliance has a 1-year low of $75.18 and a 1-year high of $89.69.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the Zacks’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The company had revenue of $30.12 billion for the quarter, compared to analysts’ expectations of $29.72 billion. During the same quarter in the prior year, the company posted $1.18 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 2.1% compared to the same quarter last year. On average, equities analysts anticipate that Walgreens Boots Alliance will post $5.00 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th were given a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a yield of 1.94%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio is presently 40.30%.
Walgreens Boots Alliance declared that its board has approved a share buyback plan on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to reacquire up to 5.9% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s board of directors believes its stock is undervalued.
Several equities analysts have commented on the stock. Needham & Company LLC set a $94.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Monday, July 17th. Pivotal Research set a $85.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Sunday, July 2nd. Guggenheim reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $77.00 price objective (down previously from $89.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, June 28th. Finally, Morgan Stanley reiterated an “overweight” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and fourteen have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $91.81.
COPYRIGHT VIOLATION WARNING: “Walgreens Boots Alliance (WBA) Earning Positive Press Coverage, Analysis Finds” was reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at https://stocknewstimes.com/2017/09/19/walgreens-boots-alliance-wba-earning-positive-press-coverage-analysis-finds.html.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the transaction, the director now owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 13.50% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.